| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | L27 domain binding | 4.28e-09 | 4 | 163 | 4 | GO:0097016 | |
| GeneOntologyMolecularFunction | kinase activity | CDK18 MARK1 MATK SCYL3 DGKA DAPK1 NOL9 STK32C ITPKC MAST4 DSTYK TJP2 DLG1 PRKCQ FGFR4 MAP3K7 WNK4 | 1.76e-04 | 764 | 163 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.82e-04 | 14 | 163 | 3 | GO:0097493 | |
| GeneOntologyBiologicalProcess | maintenance of apical/basal cell polarity | 1.77e-06 | 12 | 163 | 4 | GO:0035090 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of epithelial cell apical/basal polarity | 6.40e-06 | 58 | 163 | 6 | GO:0045197 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of bipolar cell polarity | 1.04e-05 | 63 | 163 | 6 | GO:0061245 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of apical/basal cell polarity | 1.04e-05 | 63 | 163 | 6 | GO:0035088 | |
| GeneOntologyBiologicalProcess | maintenance of cell polarity | 1.65e-05 | 20 | 163 | 4 | GO:0030011 | |
| GeneOntologyBiologicalProcess | protein localization to basolateral plasma membrane | 2.64e-05 | 8 | 163 | 3 | GO:1903361 | |
| GeneOntologyBiologicalProcess | skeletal system development | SOX6 COL9A1 SHOX2 RUNX1 CBS RYR1 THBS3 FBN1 FBN2 RFLNB HOXD10 MTHFD1 TJP2 DLG1 MAP3K7 USP1 | 3.10e-05 | 615 | 163 | 16 | GO:0001501 |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 3.40e-05 | 47 | 163 | 5 | GO:0045494 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | LIN7C TSC2 ACTR3 LIN7A LIN7B LLGL1 RHOBTB1 RHOBTB2 DLG1 SCRIB | 3.93e-05 | 257 | 163 | 10 | GO:0007163 |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translation | 5.58e-05 | 10 | 163 | 3 | GO:2000766 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 6.12e-05 | 218 | 163 | 9 | GO:0071897 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translational elongation | 6.21e-05 | 2 | 163 | 2 | GO:1900248 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 7.36e-05 | 277 | 163 | 10 | GO:0048705 | |
| GeneOntologyBiologicalProcess | maintenance of epithelial cell apical/basal polarity | 7.63e-05 | 11 | 163 | 3 | GO:0045199 | |
| GeneOntologyBiologicalProcess | regulation of DNA biosynthetic process | 1.15e-04 | 138 | 163 | 7 | GO:2000278 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | PLAAT4 MAPT NVL HNRNPD FBN1 DSTYK TPX2 DLG1 PDE5A PRKCQ FGFR4 MAP3K7 WNK4 | 1.45e-04 | 490 | 163 | 13 | GO:0051347 |
| GeneOntologyBiologicalProcess | retina homeostasis | 1.52e-04 | 64 | 163 | 5 | GO:0001895 | |
| GeneOntologyBiologicalProcess | cellular response to brain-derived neurotrophic factor stimulus | 1.65e-04 | 14 | 163 | 3 | GO:1990416 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translational elongation | 1.85e-04 | 3 | 163 | 2 | GO:1900247 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | PLOD3 ACACB ACSM1 CBS KAT2B MTHFD1 HPGDS LIPG ACSF3 PNPLA8 FGFR4 | 1.97e-04 | 374 | 163 | 11 | GO:0046394 |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translation | 2.03e-04 | 37 | 163 | 4 | GO:2000765 | |
| GeneOntologyBiologicalProcess | internal protein amino acid acetylation | 2.06e-04 | 15 | 163 | 3 | GO:0006475 | |
| GeneOntologyBiologicalProcess | homocysteine metabolic process | 2.06e-04 | 15 | 163 | 3 | GO:0050667 | |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | PLOD3 ACACB ACSM1 CBS KAT2B MTHFD1 HPGDS LIPG ACSF3 PNPLA8 FGFR4 | 2.12e-04 | 377 | 163 | 11 | GO:0016053 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | PLAAT4 MAPT NVL TSC2 CBS HNRNPD DNAJA3 KAT2B FBN1 DSTYK TPX2 DLG1 PDE5A PRKCQ FGFR4 MAP3K7 WNK4 | 2.39e-04 | 810 | 163 | 17 | GO:0051338 |
| GeneOntologyBiologicalProcess | vesicle targeting | 2.48e-04 | 71 | 163 | 5 | GO:0006903 | |
| GeneOntologyBiologicalProcess | bone development | 2.59e-04 | 264 | 163 | 9 | GO:0060348 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | PLOD3 ACACB ACSM1 THTPA CBS ITPKC KAT2B MTHFD1 HPGDS LIPG ACSF3 PNPLA8 FGFR4 HMGCLL1 PCK2 | 3.14e-04 | 676 | 163 | 15 | GO:0044283 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.69e-04 | 4 | 163 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | CENPF MAPT MARK1 AP1M2 LIN7A EXOC8 PREB EXOC5 KAT2B LLGL1 MEIOC DLG1 SCRIB | 4.12e-04 | 546 | 163 | 13 | GO:0051656 |
| GeneOntologyCellularComponent | MPP7-DLG1-LIN7 complex | 1.73e-08 | 5 | 162 | 4 | GO:0097025 | |
| GeneOntologyCellularComponent | postsynaptic density | LIN7C MAP1A MAPT CPEB3 DAPK1 TSC2 ACTN2 HNRNPD LIN7A ITPR1 LIN7B CPEB4 DLG1 SCRIB MAP3K7 | 2.44e-06 | 451 | 162 | 15 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | LIN7C MAP1A MAPT CPEB3 DAPK1 TSC2 ACTN2 HNRNPD LIN7A ITPR1 LIN7B CPEB4 DLG1 SCRIB MAP3K7 | 4.82e-06 | 477 | 162 | 15 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | LIN7C MAP1A MAPT CPEB3 DAPK1 TSC2 ACTN2 HNRNPD LIN7A ITPR1 LIN7B CPEB4 DLG1 SCRIB MAP3K7 | 9.09e-06 | 503 | 162 | 15 | GO:0099572 |
| GeneOntologyCellularComponent | postsynapse | LIN7C MAP1A MAPT MARK1 CPEB3 DAPK1 TSC2 ACTN2 ACTR3 HNRNPD LIN7A ITPR1 LIN7B DNAJA3 DIP2A CLCN3 UBE3A CPEB4 DLG1 SCRIB MAP3K7 ARHGAP33 | 1.30e-05 | 1018 | 162 | 22 | GO:0098794 |
| GeneOntologyCellularComponent | neuron to neuron synapse | LIN7C MAP1A MAPT CPEB3 DAPK1 TSC2 ACTN2 HNRNPD LIN7A ITPR1 LIN7B CPEB4 DLG1 SCRIB MAP3K7 | 1.44e-05 | 523 | 162 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | apical junction complex | 3.29e-05 | 158 | 162 | 8 | GO:0043296 | |
| GeneOntologyCellularComponent | myelin sheath abaxonal region | 3.71e-05 | 9 | 162 | 3 | GO:0035748 | |
| GeneOntologyCellularComponent | cell-cell junction | LIN7C NPHP4 ACTR3 LIN7A LIN7B LLGL1 FRMD6 AHNAK TJP2 DLG1 FGFR4 SCRIB DNMBP CDH8 WNK4 | 5.86e-05 | 591 | 162 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | glutamatergic synapse | CPEB2 LIN7C MARK1 CPEB3 DAPK1 TSC2 ACTN2 ACTR3 HNRNPD DIP2A CLCN3 LINGO1 UBE3A DLG1 SCRIB CPNE4 CDH8 ARHGAP33 | 6.62e-05 | 817 | 162 | 18 | GO:0098978 |
| GeneOntologyCellularComponent | bicellular tight junction | 7.36e-05 | 131 | 162 | 7 | GO:0005923 | |
| GeneOntologyCellularComponent | tight junction | 1.07e-04 | 139 | 162 | 7 | GO:0070160 | |
| GeneOntologyCellularComponent | transport vesicle | ATP6V1B2 LIN7C WDR7 AP1M2 LIN7A ITPR1 LIN7B ARFGEF3 NRSN2 CLCN3 UBE3A DLG1 FGFR4 | 2.10e-04 | 519 | 162 | 13 | GO:0030133 |
| GeneOntologyCellularComponent | adherens junction | 2.55e-04 | 212 | 162 | 8 | GO:0005912 | |
| GeneOntologyCellularComponent | aggresome | 2.56e-04 | 40 | 162 | 4 | GO:0016235 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 4.81e-04 | 293 | 162 | 9 | GO:0030658 | |
| GeneOntologyCellularComponent | anchoring junction | LIN7C ACTN2 NPHP4 ACTR3 SLC3A2 LIN7A LIN7B LLGL1 FRMD6 DSTYK AHNAK TJP2 DLG1 FGFR4 SCRIB DNMBP CDH8 WNK4 | 5.81e-04 | 976 | 162 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 6.11e-04 | 185 | 162 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | inclusion body | 6.79e-04 | 90 | 162 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 9.01e-04 | 320 | 162 | 9 | GO:0016323 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.42e-03 | 157 | 162 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.81e-03 | 354 | 162 | 9 | GO:0009925 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 2.15e-03 | 230 | 162 | 7 | GO:0098562 | |
| Domain | CEBP_ZZ | 2.64e-06 | 4 | 164 | 3 | PF16366 | |
| Domain | RRM_7 | 2.64e-06 | 4 | 164 | 3 | PF16367 | |
| Domain | CEBP_ZZ | 2.64e-06 | 4 | 164 | 3 | IPR032296 | |
| Domain | L27 | 3.85e-06 | 13 | 164 | 4 | SM00569 | |
| Domain | L27 | 3.85e-06 | 13 | 164 | 4 | PS51022 | |
| Domain | L27_dom | 3.85e-06 | 13 | 164 | 4 | IPR004172 | |
| Domain | PDZ | 3.51e-05 | 141 | 164 | 8 | PF00595 | |
| Domain | PDZ | 4.95e-05 | 148 | 164 | 8 | SM00228 | |
| Domain | - | 5.45e-05 | 150 | 164 | 8 | 2.30.42.10 | |
| Domain | PDZ | 5.71e-05 | 151 | 164 | 8 | PS50106 | |
| Domain | PDZ | 5.98e-05 | 152 | 164 | 8 | IPR001478 | |
| Domain | L27_C | 7.62e-05 | 10 | 164 | 3 | IPR014775 | |
| Domain | L27 | 7.62e-05 | 10 | 164 | 3 | PF02828 | |
| Domain | PsdUridine_synth_TruD | 7.66e-05 | 2 | 164 | 2 | IPR001656 | |
| Domain | CXorf40 | 7.66e-05 | 2 | 164 | 2 | IPR033615 | |
| Domain | TRUD | 7.66e-05 | 2 | 164 | 2 | PS50984 | |
| Domain | PsdUridine_synth_TruD_insert | 7.66e-05 | 2 | 164 | 2 | IPR011760 | |
| Domain | TruD | 7.66e-05 | 2 | 164 | 2 | PF01142 | |
| Domain | UPF0024 | 7.66e-05 | 2 | 164 | 2 | PS01268 | |
| Domain | P-loop_NTPase | ATP6V1B2 ABCA4 GNL3L NVL ABCB6 DAPK1 ABCA8 TRANK1 RHOBTB1 MTHFD1 RHOBTB2 YLPM1 TJP2 DLG1 CHD6 KIF18B DDX24 MX1 ATP5F1B | 1.69e-04 | 848 | 164 | 19 | IPR027417 |
| Domain | Arp3_met | 2.29e-04 | 3 | 164 | 2 | IPR015623 | |
| Domain | ChSh | 2.29e-04 | 3 | 164 | 2 | SM00300 | |
| Domain | Chromo_shadow_dom | 2.29e-04 | 3 | 164 | 2 | IPR008251 | |
| Domain | ASCH_domain | 2.29e-04 | 3 | 164 | 2 | IPR007374 | |
| Domain | ASCH | 2.29e-04 | 3 | 164 | 2 | SM01022 | |
| Domain | Chromo_shadow | 2.29e-04 | 3 | 164 | 2 | PF01393 | |
| Domain | FBN | 2.29e-04 | 3 | 164 | 2 | IPR011398 | |
| Domain | - | ATP6V1B2 ABCA4 GNL3L NVL ABCB6 ABCA8 TRANK1 RHOBTB1 MTHFD1 RHOBTB2 YLPM1 TJP2 DLG1 CHD6 DDX24 MX1 ATP5F1B | 3.11e-04 | 746 | 164 | 17 | 3.40.50.300 |
| Domain | ATP_synth_asu_C | 7.53e-04 | 5 | 164 | 2 | IPR000793 | |
| Domain | ATP-synt_ab_N | 7.53e-04 | 5 | 164 | 2 | PF02874 | |
| Domain | ATPase_F1/V1/A1_a/bsu_N | 7.53e-04 | 5 | 164 | 2 | IPR004100 | |
| Domain | PHOSPHOPANTETHEINE | 7.53e-04 | 5 | 164 | 2 | PS00012 | |
| Domain | ATPase_a/bsu_AS | 7.53e-04 | 5 | 164 | 2 | IPR020003 | |
| Domain | ATP-synt_ab_C | 7.53e-04 | 5 | 164 | 2 | PF00306 | |
| Domain | ATP-synt_ab | 7.53e-04 | 5 | 164 | 2 | PF00006 | |
| Domain | ATPASE_ALPHA_BETA | 7.53e-04 | 5 | 164 | 2 | PS00152 | |
| Domain | SH3_2 | 9.64e-04 | 86 | 164 | 5 | PF07653 | |
| Domain | SH3_2 | 9.64e-04 | 86 | 164 | 5 | IPR011511 | |
| Domain | RIH_assoc-dom | 1.12e-03 | 6 | 164 | 2 | IPR013662 | |
| Domain | ATPase_F1/V1/A1_a/bsu_nucl-bd | 1.12e-03 | 6 | 164 | 2 | IPR000194 | |
| Domain | Ins145_P3_rec | 1.12e-03 | 6 | 164 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.12e-03 | 6 | 164 | 2 | PF08454 | |
| Domain | RIH_dom | 1.12e-03 | 6 | 164 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.12e-03 | 6 | 164 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.12e-03 | 6 | 164 | 2 | IPR015925 | |
| Domain | - | 1.12e-03 | 6 | 164 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.12e-03 | 6 | 164 | 2 | PF01365 | |
| Domain | Chromo_domain | 1.17e-03 | 24 | 164 | 3 | IPR023780 | |
| Domain | S_TKc | CDK18 MARK1 SCYL3 DAPK1 STK32C MAST4 DSTYK PRKCQ MAP3K7 WNK4 | 1.30e-03 | 359 | 164 | 10 | SM00220 |
| Domain | Prot_kinase_dom | CDK18 MARK1 MATK SCYL3 DAPK1 STK32C MAST4 DSTYK PRKCQ FGFR4 MAP3K7 WNK4 | 1.31e-03 | 489 | 164 | 12 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CDK18 MARK1 MATK SCYL3 DAPK1 STK32C MAST4 DSTYK PRKCQ FGFR4 MAP3K7 WNK4 | 1.40e-03 | 493 | 164 | 12 | PS50011 |
| Domain | Chromo | 1.49e-03 | 26 | 164 | 3 | PF00385 | |
| Domain | TB | 1.56e-03 | 7 | 164 | 2 | PF00683 | |
| Domain | CHROMO_1 | 1.85e-03 | 28 | 164 | 3 | PS00598 | |
| Domain | CHROMO_2 | 1.85e-03 | 28 | 164 | 3 | PS50013 | |
| Domain | Pkinase | CDK18 MARK1 SCYL3 DAPK1 STK32C MAST4 DSTYK PRKCQ MAP3K7 WNK4 | 2.02e-03 | 381 | 164 | 10 | PF00069 |
| Domain | - | 2.07e-03 | 8 | 164 | 2 | 3.90.290.10 | |
| Domain | AMP-binding | 2.27e-03 | 30 | 164 | 3 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 2.27e-03 | 30 | 164 | 3 | IPR000873 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.79e-05 | 44 | 115 | 5 | M27934 | |
| Pubmed | ACACB MAP1A MAPT MARK1 IARS1 TNRC6B ACTR3B SLC3A2 LIN7A ITPR1 PREB ARFGEF3 DNAJA3 UBE3A MTHFD1 CPEB4 TJP2 UBR3 DLG1 CPNE4 MAP3K7 PCK2 LRRFIP1 ATP5F1B | 1.03e-09 | 1139 | 165 | 24 | 36417873 | |
| Pubmed | 2.43e-09 | 5 | 165 | 4 | 17237226 | ||
| Pubmed | SOX6 ATP6V1B2 XRN2 KDM5A TSC2 ACTR3B RUNX1 CBS DIP2A FBN1 NEUROD2 WIZ UBE3A ATRNL1 YLPM1 USP32 DLG1 C1S CHD6 SCRIB SMURF2 AFF4 LRRFIP1 ATP5F1B | 1.07e-08 | 1285 | 165 | 24 | 35914814 | |
| Pubmed | GNL3L MAP1A KDM5A MAPT POLD1 TNRC6B ZNF318 ABCA8 PAGE5 DNAJA3 KAT7 KAT2B FBN2 WIZ CBX5 CPEB4 CBX1 SCRIB KIF18B DDX24 AFF4 ARHGAP33 | 1.81e-08 | 1116 | 165 | 22 | 31753913 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | XRN2 GNL3L IARS1 POLD1 URB2 NOL9 RUNX1 ACTR3 HNRNPD SLC3A2 DNAJA3 KAT7 TGM3 LLGL1 UBE3A MTHFD1 AHNAK CBX1 PDCD11 SCRIB KIF18B DDX24 PCK2 ATP5F1B | 2.84e-08 | 1353 | 165 | 24 | 29467282 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | XRN2 GNL3L PLOD3 CENPF IARS1 NOL9 ACTR3 HNRNPD SLC3A2 MRPL39 DNAJA3 TGM3 MTHFD1 AHNAK TPX2 TJP2 CBX1 PDCD11 DLG1 SCRIB DDX24 LRRFIP1 ATP5F1B | 3.25e-08 | 1257 | 165 | 23 | 36526897 |
| Pubmed | 3.31e-08 | 20 | 165 | 5 | 19726564 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | XRN2 MAP1A WDR7 KDM5A MARK1 TNRC6B GTF2IRD1 HNRNPD LIN7A DNAJA3 LLGL1 WIZ CBX5 CPEB4 YLPM1 CBX1 CHD6 DOCK6 DDX24 AFF4 ARHGAP33 | 5.09e-08 | 1082 | 165 | 21 | 38697112 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP1A KDM5A MAPT IARS1 TNRC6B ACTR3 HNRNPD WIZ AHNAK CPEB4 YLPM1 TJP2 CBX1 KIF18B DNMBP DDX24 LRRFIP1 | 7.33e-08 | 724 | 165 | 17 | 36232890 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | XRN2 ACACB KDM5A IARS1 POLD1 NOL9 ACTR3 HNRNPD PTGR3 MRPL39 DNAJA3 MEIOC MTHFD1 CBX5 AHNAK TJP2 CBX1 PDCD11 CHD6 PRKCQ DDX24 PCK2 ATP5F1B | 7.65e-08 | 1318 | 165 | 23 | 30463901 |
| Pubmed | CPEB2 IL12RB1 ATP6V1B2 MAP1A WDR7 MAPT MARK1 IARS1 DAPK1 ACTN2 ALDH1L1 ACTR3B ACTR3 HNRNPD SLC3A2 DIP2A MTHFD1 CPEB4 TJP2 DLG1 SCRIB CPNE4 LRRFIP1 ATP5F1B | 8.08e-08 | 1431 | 165 | 24 | 37142655 | |
| Pubmed | 1.00e-07 | 10 | 165 | 4 | 14960569 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 23653213 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 21849460 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 19098995 | ||
| Pubmed | CPEB2, a novel putative translational regulator in mouse haploid germ cells. | 1.05e-07 | 3 | 165 | 3 | 12672660 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | XRN2 KDM5A MAPT MATK ZNF318 RUNX1 GTF2IRD1 REXO1 HNRNPD YLPM1 TPX2 TJP2 DLG1 SCRIB DNMBP DDX24 LRRFIP1 | 1.89e-07 | 774 | 165 | 17 | 15302935 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | XRN2 GNL3L CENPF POLD1 SQLE URB2 NOL9 HNRNPD SLC3A2 KAT7 MTHFD1 AHNAK YLPM1 TPX2 PDCD11 KIF18B DDX24 AFF4 ATP5F1B | 2.70e-07 | 989 | 165 | 19 | 36424410 |
| Pubmed | CPEB2-dependent translation of long 3'-UTR Ucp1 mRNA promotes thermogenesis in brown adipose tissue. | 4.18e-07 | 4 | 165 | 3 | 30177570 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 17548676 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 16482544 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 12871996 | ||
| Pubmed | Regulation of the hDlg/hScrib/Hugl-1 tumour suppressor complex. | 4.18e-07 | 4 | 165 | 3 | 18793635 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 17923534 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 18286632 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 14596909 | ||
| Pubmed | ATP6V1B2 XRN2 PLOD3 NVL ACTR3B ACTR3 KAT7 RFLNB CBX5 AHNAK YLPM1 CBX1 DLG1 SCRIB LRRFIP1 | 6.72e-07 | 660 | 165 | 15 | 32780723 | |
| Pubmed | ATP6V1B2 GNL3L PLOD3 LIN7C KDM5A POLD1 TNRC6B ABCB6 ZNF318 URB2 NOL9 SLC3A2 PREB WIZ MTHFD1 TPX2 CBX1 PDCD11 DLG1 CHD6 DNMBP AFF4 ATP5F1B | 7.12e-07 | 1497 | 165 | 23 | 31527615 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | GNL3L PLOD3 ACACB CENPF POLD1 ALDH1L1 DIP2A TRANK1 MTHFD1 USP32 TJP2 DDX24 WNK4 | 8.21e-07 | 497 | 165 | 13 | 36774506 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | XRN2 CENPF KDM5A ZNF318 NOL9 RUNX1 GTF2IRD1 HNRNPD PREB DNAJA3 KAT7 WIZ CBX5 AHNAK YLPM1 TPX2 PDCD11 CHD6 KIF18B DDX24 ATP5F1B | 9.56e-07 | 1294 | 165 | 21 | 30804502 |
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 10341223 | ||
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 11104771 | ||
| Pubmed | A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons. | 1.04e-06 | 5 | 165 | 3 | 20639532 | |
| Pubmed | XRN2 GNL3L PLOD3 POLD1 TSC2 ACTR3 HNRNPD SLC3A2 ITPR1 ARFGEF3 KAT7 EXOC5 RFLNB AHNAK TJP2 PDCD11 SCRIB DDX24 PCK2 MX1 LRRFIP1 ATP5F1B | 1.40e-06 | 1440 | 165 | 22 | 30833792 | |
| Pubmed | Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing. | 1.42e-06 | 18 | 165 | 4 | 30111840 | |
| Pubmed | 1.79e-06 | 19 | 165 | 4 | 15024025 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ATP6V1B2 XRN2 CENPF IARS1 ZNF318 URB2 ACTR3 HNRNPD SLC3A2 MTHFD1 CBX5 AHNAK YLPM1 TJP2 CBX1 PDCD11 SCRIB ATP5F1B | 2.01e-06 | 1024 | 165 | 18 | 24711643 |
| Pubmed | 2.08e-06 | 6 | 165 | 3 | 15863617 | ||
| Pubmed | CDK18 ATP6V1B2 PLOD3 POLD1 NVL NOL9 SLC3A2 ITPR1 PREB MRPL39 DNAJA3 DIP2A EXOC5 LLGL1 CBX5 PDCD11 DLG1 PNPLA8 SCRIB DDX24 PUS7 ATP5F1B | 2.35e-06 | 1487 | 165 | 22 | 33957083 | |
| Pubmed | TNRC6B ZNF318 SLC3A2 WIZ RFLNB AHNAK YLPM1 TPX2 TJP2 PDCD11 DLG1 SCRIB LRRFIP1 | 2.46e-06 | 549 | 165 | 13 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GNL3L ACACB MAP1A TNRC6B ZNF318 CBS SLC3A2 WIZ MTHFD1 AHNAK YLPM1 TPX2 CBX1 SCRIB AFF4 PUS7 ATP5F1B | 2.47e-06 | 934 | 165 | 17 | 33916271 |
| Pubmed | 2.65e-06 | 46 | 165 | 5 | 35022314 | ||
| Pubmed | ATP6V1B2 GNL3L TNRC6B KAT7 KAT2B RFLNB CBX5 AHNAK TPX2 CHD6 WDR90 SCRIB KIF18B MAP3K7 | 2.74e-06 | 645 | 165 | 14 | 25281560 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | IARS1 TNRC6B ACTN2 ACTR3B ACTR3 EXOC8 TGM3 MTHFD1 AHNAK UBR3 NCEH1 SCRIB MX1 ATP5F1B | 2.84e-06 | 647 | 165 | 14 | 26618866 |
| Pubmed | XRN2 GNL3L HLA-DMA IARS1 POLD1 NVL DGKA NOL9 ACTR3 SLC3A2 EXOC8 ITPR1 PREB CLCN3 MTHFD1 AHNAK NCEH1 DDX24 ATP5F1B | 3.17e-06 | 1168 | 165 | 19 | 19946888 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | IARS1 HNRNPD KAT7 WIZ CBX5 AHNAK TPX2 CBX1 PDCD11 KIF18B DDX24 | 3.18e-06 | 394 | 165 | 11 | 27248496 |
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 9753324 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | NVL DAPK1 NOL9 ACTR3 HNRNPD SLC3A2 PREB DNAJA3 CBX1 SCRIB KIF18B | 3.67e-06 | 400 | 165 | 11 | 35013556 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK18 KDM5A MAPT MATK TSC2 STK32C ARFGEF3 MAST4 FRMD6 DSTYK AHNAK TJP2 SCRIB DNMBP DOCK6 WNK4 | 3.82e-06 | 861 | 165 | 16 | 36931259 |
| Pubmed | SOX6 XRN2 ACACB KDM5A IARS1 TNRC6B ZNF318 ACTR3 MRPL39 KAT2B FBN1 FBN2 WIZ RFLNB UBXN7 YLPM1 TPX2 CBX1 PDCD11 CHD6 DDX24 | 4.52e-06 | 1429 | 165 | 21 | 35140242 | |
| Pubmed | MARK1 NPHP4 ABCA8 REXO1 CMIP RHOBTB1 ATRNL1 DSTYK CPEB4 UBR3 NCEH1 PUS7 | 4.59e-06 | 493 | 165 | 12 | 15368895 | |
| Pubmed | ACACB WDR7 SCYL3 TNRC6B ZNF318 SLC3A2 ARFGEF3 WIZ FRMD6 MTHFD1 AHNAK TJP2 DLG1 SCRIB MAP3K7 | 4.94e-06 | 777 | 165 | 15 | 35844135 | |
| Pubmed | 5.57e-06 | 339 | 165 | 10 | 30415952 | ||
| Pubmed | Polarity protein complex Scribble/Lgl/Dlg and epithelial cell barriers. | 5.77e-06 | 8 | 165 | 3 | 23397623 | |
| Pubmed | 5.77e-06 | 8 | 165 | 3 | 12351654 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 7.26e-06 | 148 | 165 | 7 | 32538781 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | XRN2 MAP1A CENPF POLD1 URB2 CBS ACTR3 HNRNPD UBE3A CBX5 PDCD11 SCRIB DDX24 PCK2 | 7.42e-06 | 704 | 165 | 14 | 29955894 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | XRN2 LIN7C IARS1 SQLE NOL9 ACTR3 HNRNPD SLC3A2 MRPL39 TGM3 AHNAK YLPM1 TJP2 PDCD11 DLG1 SCRIB DDX24 PUS7 LRRFIP1 ATP5F1B | 8.29e-06 | 1367 | 165 | 20 | 32687490 |
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 19064578 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 9.64e-06 | 361 | 165 | 10 | 30344098 | |
| Pubmed | Neurotransmitter release regulated by a MALS-liprin-alpha presynaptic complex. | 1.22e-05 | 30 | 165 | 4 | 16186258 | |
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 27810937 | ||
| Pubmed | 1.34e-05 | 226 | 165 | 8 | 31452512 | ||
| Pubmed | XRN2 GNL3L DGKA NOL9 EXOC8 ITPR1 PREB DIP2A LLGL1 CLCN3 DSTYK DLG1 SCRIB | 1.50e-05 | 650 | 165 | 13 | 38777146 | |
| Pubmed | XRN2 CENPF NVL ZNF318 URB2 NOL9 ACTR3 TGM3 AHNAK YLPM1 TJP2 PDCD11 DDX24 | 1.57e-05 | 653 | 165 | 13 | 22586326 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.57e-05 | 231 | 165 | 8 | 16452087 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ATP6V1B2 PLOD3 CENPF MARK1 NVL TNRC6B THTPA ZNF318 URB2 FBN1 FBN2 UBE3A IL17RA DOCK6 | 1.60e-05 | 754 | 165 | 14 | 33060197 |
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 20737570 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CRYBG2 PLOD3 TSC2 STK32C GTF2IRD1 NPHP4 REXO1 RYR1 DIP2A WIZ AHNAK PDCD11 WDR90 DNMBP DOCK6 SMURF2 ARHGAP33 | 2.20e-05 | 1105 | 165 | 17 | 35748872 |
| Pubmed | Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. | 2.24e-05 | 12 | 165 | 3 | 10846156 | |
| Pubmed | 2.24e-05 | 12 | 165 | 3 | 36779913 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12399449 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21851253 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9268366 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 2.24e-05 | 2 | 165 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 2.24e-05 | 2 | 165 | 2 | 21440062 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15131124 | ||
| Pubmed | Scrib and Dlg1 polarity proteins regulate Ag presentation in human dendritic cells. | 2.24e-05 | 2 | 165 | 2 | 32293058 | |
| Pubmed | E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6. | 2.24e-05 | 2 | 165 | 2 | 18298802 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 17891782 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16385466 | ||
| Pubmed | Scribble, Lgl1, and myosin II form a complex in vivo to promote directed cell migration. | 2.24e-05 | 2 | 165 | 2 | 32697665 | |
| Pubmed | Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. | 2.24e-05 | 2 | 165 | 2 | 11242054 | |
| Pubmed | Interaction of glutamic-acid-rich proteins with the cGMP signalling pathway in rod photoreceptors. | 2.24e-05 | 2 | 165 | 2 | 10466724 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 2.24e-05 | 2 | 165 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 2.24e-05 | 2 | 165 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 2.24e-05 | 2 | 165 | 2 | 8307578 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12654335 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 2.24e-05 | 2 | 165 | 2 | 7744963 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 2.24e-05 | 2 | 165 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 2.24e-05 | 2 | 165 | 2 | 24833718 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 32440535 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24265020 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 20529844 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 35501367 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23133647 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16103886 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16619250 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 22792261 | ||
| Interaction | APBA1 interactions | 1.91e-06 | 103 | 163 | 8 | int:APBA1 | |
| Interaction | KCNJ4 interactions | 1.81e-05 | 20 | 163 | 4 | int:KCNJ4 | |
| Interaction | CCDC71 interactions | 2.57e-05 | 72 | 163 | 6 | int:CCDC71 | |
| Interaction | RARRES1 interactions | 2.69e-05 | 22 | 163 | 4 | int:RARRES1 | |
| Interaction | ARHGEF26 interactions | 2.74e-05 | 44 | 163 | 5 | int:ARHGEF26 | |
| Interaction | MPP2 interactions | 3.79e-05 | 47 | 163 | 5 | int:MPP2 | |
| Interaction | WWTR1 interactions | LIN7C TNRC6B DAPK1 ZNF318 RUNX1 SLC3A2 WIZ RFLNB PDCD11 DLG1 SCRIB USP1 LRRFIP1 | 4.07e-05 | 422 | 163 | 13 | int:WWTR1 |
| Interaction | PXDC1 interactions | 4.21e-05 | 9 | 163 | 3 | int:PXDC1 | |
| Interaction | AR interactions | XRN2 IARS1 POLD1 MATK NVL AP1M2 ZNF318 ACTN2 RUNX1 ACTR3 HNRNPD KAT7 KAT2B WIZ UBE3A CBX5 YLPM1 TPX2 CBX1 AFF4 ATP5F1B | 5.25e-05 | 992 | 163 | 21 | int:AR |
| Interaction | KCTD13 interactions | CPEB2 IL12RB1 ATP6V1B2 MAP1A WDR7 MAPT MARK1 IARS1 DAPK1 ACTN2 ALDH1L1 ACTR3B ACTR3 HNRNPD SLC3A2 KAT7 DIP2A MTHFD1 CPEB4 UBXN7 TJP2 DLG1 SCRIB CPNE4 LRRFIP1 ATP5F1B | 5.41e-05 | 1394 | 163 | 26 | int:KCTD13 |
| Interaction | PARP1 interactions | MAPT POLD1 NVL DAPK1 URB2 NOL9 ACTR3 HNRNPD SLC3A2 PREB DNAJA3 KAT7 KAT2B WIZ CBX5 UBXN7 TPX2 CBX1 PDCD11 CHD6 SCRIB KIF18B USP1 SMURF2 AFF4 | 5.71e-05 | 1316 | 163 | 25 | int:PARP1 |
| Interaction | BRCA1 interactions | XRN2 GNL3L PLOD3 CENPF MAPT IARS1 POLD1 MATK TNRC6B RUNX1 GTF2IRD1 HNRNPD ITPR1 MRPL39 DNAJA3 WIZ UBE3A MTHFD1 CBX5 AHNAK TPX2 CBX1 DDX24 LRRFIP1 | 6.84e-05 | 1249 | 163 | 24 | int:BRCA1 |
| Interaction | ZNF330 interactions | XRN2 GNL3L PLOD3 NVL URB2 NOL9 WIZ CBX5 PDCD11 KIF18B DDX24 AFF4 PUS7 | 7.15e-05 | 446 | 163 | 13 | int:ZNF330 |
| Interaction | KCNJ12 interactions | 7.26e-05 | 28 | 163 | 4 | int:KCNJ12 | |
| Interaction | GTF2IRD1 interactions | 8.00e-05 | 88 | 163 | 6 | int:GTF2IRD1 | |
| Interaction | HSP90AA1 interactions | CDK18 ATP6V1B2 PLAAT4 MAPT MATK DAPK1 HIF3A ALDH1L1 STK32C NPHP4 SLC3A2 PREB DNAJA3 LLGL1 RHOBTB1 MTHFD1 RHOBTB2 PRKCQ FGFR4 SCRIB MAP3K7 DDX24 WNK4 ATP5F1B | 8.14e-05 | 1263 | 163 | 24 | int:HSP90AA1 |
| Interaction | MEN1 interactions | XRN2 GNL3L IARS1 NVL TSC2 NOL9 RUNX1 CBS SLC3A2 DNAJA3 KAT7 WIZ UBE3A UBXN7 YLPM1 TPX2 TJP2 PDCD11 DDX24 AFF4 ATP5F1B | 8.82e-05 | 1029 | 163 | 21 | int:MEN1 |
| Interaction | MECP2 interactions | XRN2 MAP1A WDR7 KDM5A MARK1 NVL TNRC6B URB2 GTF2IRD1 HNRNPD LIN7A DNAJA3 LLGL1 WIZ CBX5 CPEB4 YLPM1 CBX1 PDCD11 CHD6 DOCK6 DDX24 AFF4 ARHGAP33 | 1.09e-04 | 1287 | 163 | 24 | int:MECP2 |
| Interaction | DGCR2 interactions | 1.15e-04 | 181 | 163 | 8 | int:DGCR2 | |
| Interaction | TUBA1A interactions | CPEB2 IL12RB1 ATP6V1B2 MAPT AP1M2 THTPA NPHP4 DNAJA3 DFFA THBS3 LLGL1 USP32 WDR90 DNMBP MX1 LRRFIP1 ATP5F1B | 1.25e-04 | 749 | 163 | 17 | int:TUBA1A |
| GeneFamily | Membrane associated guanylate kinases|PDZ domain containing|Scribble complex | 9.72e-07 | 4 | 114 | 3 | 1224 | |
| GeneFamily | PDZ domain containing | 5.38e-06 | 152 | 114 | 8 | 1220 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.99e-05 | 9 | 114 | 3 | 1223 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.01e-03 | 181 | 114 | 6 | 694 | |
| GeneFamily | Chromobox family | 1.08e-03 | 8 | 114 | 2 | 976 | |
| GeneFamily | Exocyst complex | 1.38e-03 | 9 | 114 | 2 | 1055 | |
| Coexpression | TSUNODA_CISPLATIN_RESISTANCE_DN | 1.57e-05 | 50 | 165 | 5 | M5014 | |
| Coexpression | HU_FETAL_RETINA_RPE | 1.68e-05 | 291 | 165 | 10 | M39271 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | CPEB2 SCYL3 TNRC6B KRBOX4 ACTR3B CBS SLC3A2 LIN7A ITPR1 KAT2B CBX5 CPEB4 PDCD11 NCEH1 PNPLA8 CHD6 PCK2 LRRFIP1 | 2.92e-05 | 942 | 165 | 18 | M8144 |
| Coexpression | FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS | 2.96e-05 | 311 | 165 | 10 | M61 | |
| Coexpression | CYCLIN_D1_KE_.V1_DN | 2.97e-05 | 191 | 165 | 8 | M2647 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ATP6V1B2 MAP1A WDR7 MAPT MARK1 NEXMIF ZNF318 EXOC5 KAT2B MAST4 CLCN3 ATRNL1 DSTYK CPEB4 DDX24 USP1 HMGCLL1 AFF4 | 3.08e-05 | 946 | 165 | 18 | M39169 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | CPEB2 SCYL3 TNRC6B KRBOX4 CBS SLC3A2 LIN7A ITPR1 KAT2B CBX5 CPEB4 NCEH1 PNPLA8 CHD6 PCK2 LRRFIP1 | 3.48e-05 | 778 | 165 | 16 | M17915 |
| Coexpression | IGARASHI_ATF4_TARGETS_DN | 3.71e-05 | 98 | 165 | 6 | M4779 | |
| Coexpression | GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP | 4.12e-05 | 200 | 165 | 8 | M6480 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN | 4.12e-05 | 200 | 165 | 8 | M6554 | |
| ToppCell | BAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 9.55e-09 | 161 | 165 | 9 | 7a6e8ed0b5d999efce8945d8083ab01d71be9a92 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-07 | 168 | 165 | 8 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-07 | 168 | 165 | 8 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-07 | 180 | 165 | 8 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-07 | 190 | 165 | 8 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-07 | 191 | 165 | 8 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-07 | 191 | 165 | 8 | abdd93b2313e635f75a750d051a6a01ddc4e2df9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.92e-07 | 195 | 165 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.37e-07 | 200 | 165 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.37e-07 | 200 | 165 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.37e-07 | 200 | 165 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.02e-06 | 157 | 165 | 7 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 165 | 165 | 7 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 165 | 165 | 7 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 165 | 165 | 7 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-06 | 172 | 165 | 7 | 1565f38266891c3acf49778838de134c5dee5460 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 176 | 165 | 7 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-06 | 181 | 165 | 7 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 5.16e-06 | 181 | 165 | 7 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 184 | 165 | 7 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.75e-06 | 184 | 165 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.96e-06 | 185 | 165 | 7 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-06 | 186 | 165 | 7 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-06 | 187 | 165 | 7 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 6.40e-06 | 187 | 165 | 7 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 6.62e-06 | 188 | 165 | 7 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 6.62e-06 | 188 | 165 | 7 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.86e-06 | 189 | 165 | 7 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.86e-06 | 189 | 165 | 7 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.86e-06 | 189 | 165 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.86e-06 | 189 | 165 | 7 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.10e-06 | 190 | 165 | 7 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.34e-06 | 191 | 165 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.60e-06 | 192 | 165 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.60e-06 | 192 | 165 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.60e-06 | 192 | 165 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.86e-06 | 193 | 165 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.86e-06 | 193 | 165 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.13e-06 | 194 | 165 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.13e-06 | 194 | 165 | 7 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.41e-06 | 195 | 165 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-06 | 195 | 165 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 8.41e-06 | 195 | 165 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-06 | 195 | 165 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 8.69e-06 | 196 | 165 | 7 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 8.69e-06 | 196 | 165 | 7 | 36ed1918f70b6f5760bb088b15ce422998055cc7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.69e-06 | 196 | 165 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 9.28e-06 | 198 | 165 | 7 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 9.28e-06 | 198 | 165 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.59e-06 | 199 | 165 | 7 | 6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.59e-06 | 199 | 165 | 7 | cdcdef1d95a8e476de016b1e11ee010438834be0 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.59e-06 | 199 | 165 | 7 | 85b3b1ad01368dae4adbc9da7efc148e49992f69 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.59e-06 | 199 | 165 | 7 | e3b69608c834bd8ce6bedde298a2763cc0d7d573 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.59e-06 | 199 | 165 | 7 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.59e-06 | 199 | 165 | 7 | c7d6a8398f2419b726a0461585d1ee0561654e3b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.59e-06 | 199 | 165 | 7 | 1aa99d21bf61b86df4a966dc47634044430aa39f | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.59e-06 | 199 | 165 | 7 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 165 | 7 | 0cf7208eab0dc58fbea35e256c5cb55cdd4a4928 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 165 | 7 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.91e-06 | 200 | 165 | 7 | 5d11a2c0021805e78d97dc1638bf73ca1faede66 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 165 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 9.91e-06 | 200 | 165 | 7 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 165 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 165 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 9.91e-06 | 200 | 165 | 7 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | (06)_Krt4/13+-(2)_48hpi|(06)_Krt4/13+ / shred by cell type and Timepoint | 1.44e-05 | 40 | 165 | 4 | 1e42cd186ee06ac9345e16ede649a72c15bdf2f8 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 2.95e-05 | 160 | 165 | 6 | d288b0a315f6adc0be4bdc89fa67bf93679a743f | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-05 | 163 | 165 | 6 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.28e-05 | 163 | 165 | 6 | f21951e63188eb0c04675a8f81a0da495c26c007 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 3.39e-05 | 164 | 165 | 6 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 172 | 165 | 6 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 172 | 165 | 6 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 172 | 165 | 6 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.57e-05 | 173 | 165 | 6 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.57e-05 | 173 | 165 | 6 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-05 | 173 | 165 | 6 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.87e-05 | 175 | 165 | 6 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.87e-05 | 175 | 165 | 6 | 8958c5c30437d20a4abd70d7527990f7e2a68b93 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.03e-05 | 176 | 165 | 6 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-05 | 178 | 165 | 6 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.36e-05 | 178 | 165 | 6 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-05 | 179 | 165 | 6 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-05 | 179 | 165 | 6 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 5.88e-05 | 181 | 165 | 6 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 182 | 165 | 6 | d41ff834b8fc1d0e23cac7ae261de5f72874e462 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 6.06e-05 | 182 | 165 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 182 | 165 | 6 | 6cde859edfe7607bd7ada89d20258413d06f4207 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 6.06e-05 | 182 | 165 | 6 | 8dd79fef8f8463ad3194f9cc07c6cacf2c886304 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-05 | 182 | 165 | 6 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 183 | 165 | 6 | bf7f1cb55ed55981b8b355d5774055c96e658ff2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.24e-05 | 183 | 165 | 6 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-05 | 183 | 165 | 6 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 183 | 165 | 6 | 9533db4db2c6ae78d7ca1682cf4efed12183396f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 184 | 165 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 184 | 165 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.44e-05 | 184 | 165 | 6 | eaef1dcde60ba14e2c7fd699d01c225487256d82 | |
| ToppCell | Cerebellum-Macroglia|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.44e-05 | 184 | 165 | 6 | 91b047a01d2cad231308279ca37fa699630f7864 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.44e-05 | 184 | 165 | 6 | bba0138c8f7e3645a688b9a4d12f6f2134ee2c08 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 184 | 165 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.44e-05 | 184 | 165 | 6 | fa73738350654066d7f9ebf78359e20ee6cbdd98 | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A | CRYBG2 GNL3L MAPT MARK1 RUNX1 WIZ FGFR4 MMP10 DOCK6 ARHGAP33 | 1.38e-06 | 191 | 165 | 10 | 3815_DN |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; PC3; HG-U133A | 1.91e-06 | 198 | 165 | 10 | 1897_UP | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; PC3; HT_HG-U133A | 1.11e-05 | 191 | 165 | 9 | 6693_UP | |
| Drug | Thonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 1.25e-05 | 194 | 165 | 9 | 6457_UP | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 165 | 9 | 4414_UP | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; HL60; HT_HG-U133A | 1.54e-05 | 199 | 165 | 9 | 1839_UP | |
| Drug | Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | 1.54e-05 | 199 | 165 | 9 | 2469_UP | |
| Drug | zoledronic acid | CPEB2 ABCA4 HLA-DMA CENPF SQLE ABCB6 DAPK1 GTF2IRD1 CBS SLC3A2 DFFA EXOC5 KAT2B FBN1 MAST4 RHOBTB1 LIPG CBX5 TPX2 DLG1 C1S PDE5A VWA3B FGFR4 MMP10 CNGB1 | 2.17e-05 | 1472 | 165 | 26 | ctd:C088658 |
| Drug | cysteinylglycine | 5.81e-05 | 57 | 165 | 5 | CID000065270 | |
| Drug | NSC 97937 | 5.91e-05 | 11 | 165 | 3 | CID000097050 | |
| Drug | AC1L9JMO | 5.91e-05 | 11 | 165 | 3 | CID000446395 | |
| Drug | rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; PC3; HT_HG-U133A | 7.08e-05 | 188 | 165 | 8 | 5980_UP | |
| Drug | Demecolcine | CPEB2 GNL3L PLAAT4 CENPF HNRNPD PTGR3 LIN7A ITPR1 FBN2 CBX5 AHNAK NCEH1 WDR90 DNMBP MAP3K7 USP1 AFF4 LRRFIP1 | 7.15e-05 | 878 | 165 | 18 | ctd:D003703 |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 7.35e-05 | 189 | 165 | 8 | 2231_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 7.91e-05 | 191 | 165 | 8 | 3605_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; HL60; HT_HG-U133A | 7.91e-05 | 191 | 165 | 8 | 6149_DN | |
| Drug | Fluspirilen [1841-19-6]; Up 200; 8.4uM; HL60; HT_HG-U133A | 8.51e-05 | 193 | 165 | 8 | 3086_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 8.51e-05 | 193 | 165 | 8 | 3412_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; HL60; HG-U133A | 8.51e-05 | 193 | 165 | 8 | 1363_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | 8.82e-05 | 194 | 165 | 8 | 6741_UP | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 8.82e-05 | 194 | 165 | 8 | 2789_UP | |
| Drug | clofibrate; Up 200; 150uM; MCF7; HG-U133A | 8.82e-05 | 194 | 165 | 8 | 263_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 5261_UP | |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 5911_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 4368_UP | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 5397_UP | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; PC3; HT_HG-U133A | 9.47e-05 | 196 | 165 | 8 | 4319_UP | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; HL60; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 2439_DN | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 6471_UP | |
| Drug | Estriol [50-27-1]; Up 200; 13.8uM; PC3; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 5866_UP | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; HL60; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 6139_DN | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 1799_DN | |
| Drug | Minoxidil [38304-91-5]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 4800_UP | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; HL60; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 2492_UP | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; PC3; HG-U133A | 1.02e-04 | 198 | 165 | 8 | 1907_UP | |
| Drug | Benzbromarone [3562-84-3]; Down 200; 9.4uM; HL60; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 1291_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 3393_UP | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 7556_DN | |
| Drug | Trolox [53188-07-1]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 6007_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 6020_UP | |
| Drug | Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 6079_DN | |
| Drug | rapamycin; Up 200; 0.1uM; HL60; HG-U133A | 1.05e-04 | 199 | 165 | 8 | 362_UP | |
| Drug | Condelphine [7633-69-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.09e-04 | 200 | 165 | 8 | 3538_UP | |
| Drug | Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.09e-04 | 200 | 165 | 8 | 6836_UP | |
| Drug | WY-14643; Up 200; 100uM; PC3; HG-U133A | 1.09e-04 | 200 | 165 | 8 | 481_UP | |
| Drug | p-Chloromercuribenzoic Acid | SOX6 CPEB2 MAP1A NEXMIF MATK SQLE ABCB6 TSC2 HIF3A NPHP4 REXO1 SLC3A2 RFLNB CBX5 DLG1 C1S DOCK6 HMGCLL1 | 1.09e-04 | 908 | 165 | 18 | ctd:D020245 |
| Disease | mean reticulocyte volume | SOX6 DPEP1 MAPT NEXMIF AP1M2 ZNF318 URB2 RUNX1 REXO1 KAT7 DIP2A KAT2B TPX2 ACSF3 C1S USP1 | 7.80e-06 | 799 | 160 | 16 | EFO_0010701 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.02e-05 | 53 | 160 | 5 | C4707243 | |
| Disease | mean arterial pressure | SOX6 MEF2B WDR7 DAPK1 ZNF318 REXO1 IKZF4 THBS3 CMIP FBN2 PXDNL CPEB4 | 1.93e-05 | 499 | 160 | 12 | EFO_0006340 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.02e-05 | 152 | 160 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | lipoprotein measurement | 2.39e-05 | 105 | 160 | 6 | EFO_0004732 | |
| Disease | developmental and epileptic encephalopathy 64 (implicated_via_orthology) | 2.92e-05 | 2 | 160 | 2 | DOID:0070375 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 5.60e-05 | 75 | 160 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 8.73e-05 | 3 | 160 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 1.74e-04 | 4 | 160 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 2.56e-04 | 23 | 160 | 3 | OBA_2045158 | |
| Disease | free cholesterol in medium HDL measurement | 2.81e-04 | 58 | 160 | 4 | EFO_0022267 | |
| Disease | cholesterol in medium HDL measurement | 3.00e-04 | 59 | 160 | 4 | EFO_0021903 | |
| Disease | C-reactive protein measurement | SOX6 IL12RB1 MAP1A HLA-DMA HIF3A ITPR1 CMIP TRANK1 LLGL1 LINGO1 LIPG DSTYK AHNAK CPNE4 AFF4 ARHGAP33 MYBPC3 | 3.11e-04 | 1206 | 160 | 17 | EFO_0004458 |
| Disease | red blood cell density measurement | SOX6 XRN2 MAPT TNRC6B RUNX1 KAT2B THBS3 NEUROD2 LINGO1 HOXD10 CPEB4 TPX2 TJP2 USP1 | 3.28e-04 | 880 | 160 | 14 | EFO_0007978 |
| Disease | waist-hip ratio | MAPT CPEB3 TNRC6B ZNF318 RUNX1 PTGR3 DNAJA3 CMIP MAST4 DSTYK AHNAK CPEB4 DLG1 PDE5A FGFR4 CPNE4 DOCK6 | 3.76e-04 | 1226 | 160 | 17 | EFO_0004343 |
| Disease | total lipids in HDL measurement | 3.87e-04 | 63 | 160 | 4 | EFO_0022307 | |
| Disease | docosahexaenoic acid measurement | 6.58e-04 | 127 | 160 | 5 | EFO_0007761 | |
| Disease | Hypoxemia | 7.58e-04 | 33 | 160 | 3 | C0700292 | |
| Disease | Hypoxia | 7.58e-04 | 33 | 160 | 3 | C0242184 | |
| Disease | Anoxemia | 7.58e-04 | 33 | 160 | 3 | C0003129 | |
| Disease | Anoxia | 7.58e-04 | 33 | 160 | 3 | C0003130 | |
| Disease | neural tube defect (is_implicated_in) | 8.01e-04 | 8 | 160 | 2 | DOID:0080074 (is_implicated_in) | |
| Disease | benign neoplasm (implicated_via_orthology) | 8.01e-04 | 8 | 160 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | cardiovascular disease | 9.12e-04 | 457 | 160 | 9 | EFO_0000319 | |
| Disease | mean corpuscular hemoglobin concentration | SOX6 XRN2 TNRC6B TSC2 ZNF318 URB2 NOL9 RUNX1 KAT2B THBS3 SLC9A2 NEUROD2 CBX5 CPEB4 USP1 | 1.04e-03 | 1105 | 160 | 15 | EFO_0004528 |
| Disease | obsolete_red blood cell distribution width | SOX6 XRN2 NVL AP1M2 ABCB6 NOL9 RUNX1 REXO1 FBN2 NEUROD2 MAST4 LIPG DSTYK CPEB4 YLPM1 C1S DOCK6 | 1.07e-03 | 1347 | 160 | 17 | EFO_0005192 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.09e-03 | 291 | 160 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | diastolic blood pressure, systolic blood pressure | SOX6 DPEP1 TNRC6B PIEZO2 CMIP FBN1 LOXL4 VWA3B CHD6 HMGCLL1 LRRFIP1 | 1.12e-03 | 670 | 160 | 11 | EFO_0006335, EFO_0006336 |
| Disease | heart disease (implicated_via_orthology) | 1.15e-03 | 38 | 160 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | adseverin measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0801358 | |
| Disease | serum albumin measurement | 1.52e-03 | 592 | 160 | 10 | EFO_0004535 | |
| Disease | phospholipids:total lipids ratio | 1.54e-03 | 227 | 160 | 6 | EFO_0020946 | |
| Disease | Marfan Syndrome | 1.56e-03 | 11 | 160 | 2 | C0024796 | |
| Disease | kidney cancer (implicated_via_orthology) | 1.56e-03 | 11 | 160 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | diet measurement | DPEP1 ACSM1 TNRC6B ACTR3B RUNX1 ITPR1 TRANK1 CBX5 DSTYK UBR3 NCEH1 CHD6 CPNE4 CNGB1 | 1.78e-03 | 1049 | 160 | 14 | EFO_0008111 |
| Disease | reticulocyte measurement | SOX6 MAPT TNRC6B ABCB6 NOL9 DNAJA3 KAT2B WIZ AHNAK CPEB4 USP32 TPX2 PDE5A ATP5F1B | 1.84e-03 | 1053 | 160 | 14 | EFO_0010700 |
| Disease | ADHD symptom measurement | 1.86e-03 | 12 | 160 | 2 | EFO_0007860 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 2.19e-03 | 13 | 160 | 2 | OBA_2045159 | |
| Disease | neurotic disorder | 2.26e-03 | 101 | 160 | 4 | EFO_0004257 | |
| Disease | apolipoprotein A 1 measurement | ACACB MAP1A ABCA8 CMIP TRANK1 LIPG YLPM1 FGFR4 DOCK6 USP1 LRRFIP1 MYBPC3 | 2.35e-03 | 848 | 160 | 12 | EFO_0004614 |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 2.40e-03 | 49 | 160 | 3 | EFO_0021897 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.43e-03 | 335 | 160 | 7 | EFO_0009931 | |
| Disease | 3-hydroxyphenylacetic acid measurement | 2.55e-03 | 14 | 160 | 2 | EFO_0010448 | |
| Disease | femoral neck bone geometry | 2.55e-03 | 14 | 160 | 2 | EFO_0004511 | |
| Disease | serum alanine aminotransferase measurement | SOX6 ALDH1L1 RUNX1 FBN1 TRANK1 DSTYK AHNAK RHOBTB2 TJP2 DNMBP MX1 ATP5F1B | 2.86e-03 | 869 | 160 | 12 | EFO_0004735 |
| Disease | mental or behavioural disorder | 2.99e-03 | 179 | 160 | 5 | EFO_0000677 | |
| Disease | creatinine measurement | DPEP1 CDK18 CENPF TNRC6B ALDH1L1 RYR1 KAT2B THBS3 SLC9A2 HOXD10 USP32 DLG1 FGFR4 | 3.10e-03 | 995 | 160 | 13 | EFO_0004518 |
| Disease | chronotype measurement | SOX6 MAPT CPEB3 TNRC6B SHOX2 ZNF318 HNRNPD LINGO1 CBX1 NCEH1 KIF18B HMGCLL1 | 3.22e-03 | 882 | 160 | 12 | EFO_0008328 |
| Disease | phospholipids in medium HDL measurement | 3.34e-03 | 55 | 160 | 3 | EFO_0022295 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 3.34e-03 | 55 | 160 | 3 | EFO_0022288 | |
| Disease | breast cancer (is_marker_for) | 3.44e-03 | 185 | 160 | 5 | DOID:1612 (is_marker_for) | |
| Disease | cancer (implicated_via_orthology) | 3.51e-03 | 268 | 160 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | SOX6 DPEP1 ACACB MAP1A MAPT TSC2 ZNF318 RUNX1 ITPR1 TRANK1 LLGL1 AHNAK MYBPC3 | 3.67e-03 | 1015 | 160 | 13 | EFO_0004533 |
| Disease | Multiple congenital anomalies | 3.77e-03 | 17 | 160 | 2 | C0000772 | |
| Disease | basal cell carcinoma | 3.77e-03 | 189 | 160 | 5 | EFO_0004193 | |
| Disease | total lipids in medium HDL measurement | 3.88e-03 | 58 | 160 | 3 | EFO_0022310 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.05e-03 | 276 | 160 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | testosterone measurement | SOX6 MAP1A MAPT ZNF318 GTF2IRD1 ABCA8 REXO1 KAT2B CMIP FBN2 MTHFD1 CPEB4 PRKCQ DNMBP HMGCLL1 | 4.07e-03 | 1275 | 160 | 15 | EFO_0004908 |
| Disease | Colorectal Neoplasms | 4.13e-03 | 277 | 160 | 6 | C0009404 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 4.22e-03 | 18 | 160 | 2 | OBA_2045155 | |
| Disease | response to mepolizumab, Glucocorticoid use measurement | 4.22e-03 | 18 | 160 | 2 | EFO_0008459, EFO_0009942 | |
| Disease | disease free survival | 4.22e-03 | 18 | 160 | 2 | EFO_0000409 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.33e-03 | 121 | 160 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | free cholesterol in HDL measurement | 4.47e-03 | 61 | 160 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 4.47e-03 | 61 | 160 | 3 | EFO_0022293 | |
| Disease | prion disease | 4.70e-03 | 19 | 160 | 2 | EFO_0004720 | |
| Disease | Acute Myeloid Leukemia, M1 | 4.85e-03 | 125 | 160 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 4.85e-03 | 125 | 160 | 4 | C1879321 | |
| Disease | Colorectal Carcinoma | 5.11e-03 | 702 | 160 | 10 | C0009402 | |
| Disease | carcinoma (implicated_via_orthology) | 5.12e-03 | 64 | 160 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 5.21e-03 | 20 | 160 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 5.21e-03 | 20 | 160 | 2 | OBA_2045071 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FAKAGPEGIEPRGEI | 856 | Q14146 | |
| LEPIPRKGGKDVFQV | 131 | Q8TE69 | |
| LEPIPRKGGKDVFQV | 131 | Q96DE9 | |
| KSLVPVEEPIAFGGK | 861 | P53355 | |
| LEVISGERLPKPDRG | 76 | P35609 | |
| EKEEVEGRPPIGVKF | 366 | Q9Y6Q5 | |
| GFERGLEPEKIIGAT | 116 | P45973 | |
| GGPITREASKEIPDF | 1591 | P78363 | |
| TGRPLFPGSTVKEEL | 336 | Q07002 | |
| EELSGGRIKPKPVEV | 351 | Q9P1U1 | |
| PDGESDEVGVIPSKR | 631 | Q12959 | |
| EFPRDRLVLGKPLGE | 461 | P22455 | |
| PGIPVEELFSLLREG | 691 | P22455 | |
| RPGRFDKEIEIGVPN | 511 | Q8NB90 | |
| IEETKPLLGGDVSAP | 16 | Q8IY22 | |
| PERIKREDFVGLPEA | 951 | O94983 | |
| ETEVKDLPGAGPLRF | 571 | Q9NP58 | |
| LEGDLRGPQVDVKGP | 1806 | Q09666 | |
| PKVEGDLKGPEVDIR | 2986 | Q09666 | |
| DLKGPEVDIRGPQVD | 2991 | Q09666 | |
| PKVEGDLKGPEVDIR | 4616 | Q09666 | |
| LRGPDVKLEGPDVSL | 5266 | Q09666 | |
| LIEFEKSLAGPGTEP | 556 | Q6XZF7 | |
| PGFEEKEGELLVRGP | 416 | Q4G176 | |
| DAGVPESGEIRTLKP | 6 | O00273 | |
| NVIGEPIDERGPIKT | 146 | P06576 | |
| EEPRGGLKIESETPV | 576 | Q9UHB7 | |
| EPAAAGLGVETERPK | 96 | Q96DU7 | |
| LPSKGVQEERLGTEP | 506 | O15381 | |
| ALEVPAAAVGGEKRP | 756 | Q15334 | |
| GGVLEPEGTVEIKFR | 2226 | O00763 | |
| FPRLIADDFPGVEPK | 421 | P09238 | |
| AVKLVGPEEALSPGE | 356 | O60568 | |
| LPGASEKIGAREPEE | 671 | Q5SY16 | |
| FEEPLLPPGTGIVKR | 606 | Q96F46 | |
| EEKVGSPERPLSDLG | 501 | O95251 | |
| FREGPVEIGLPCSIK | 311 | Q04759 | |
| KLRLVGPESKPEEGR | 31 | Q96JB6 | |
| PRVVELPKTDEGLGF | 106 | O14910 | |
| PRVVELPKTDEGLGF | 91 | Q9HAP6 | |
| PRVVELPKTEEGLGF | 91 | Q9NUP9 | |
| VPEVPEEQGSKDRGL | 596 | P78559 | |
| RPKPGELAFRKGDVV | 61 | P42679 | |
| FKDGVRQIPIESIPG | 691 | Q92831 | |
| GVGDVLRKPSKEEPL | 2556 | Q14643 | |
| LPFGKIPILEVDGLT | 46 | O60760 | |
| DSARETPIGLVPKEG | 566 | Q16822 | |
| FDRPLRPIVVKDSEG | 106 | O76074 | |
| DFDGVEVRVFEGPPK | 86 | Q6PIU2 | |
| VLREAGEKKAPEGSP | 11 | Q9H4S2 | |
| EVITRRKPFDEIGGP | 221 | O43318 | |
| KDGPEIGLRLFKDVP | 411 | P23743 | |
| SPVPFGPEGRLEDKL | 21 | Q9Y5X9 | |
| PEGIPTETRLLDLGK | 66 | Q96FE5 | |
| VPPKLEGIGEGEFLV | 86 | Q9GZP1 | |
| LPVVEKRFEEGVGKP | 686 | Q8IYI6 | |
| GPLAIREDPDKGVVV | 171 | Q86Y91 | |
| KDVIVPENGEPVGTR | 441 | Q6XUX3 | |
| GFPVKDGRRKILPEE | 421 | P29375 | |
| PEEPGEKFRRLAGEG | 106 | Q02080 | |
| VGPGEPRDIFLKVAS | 1186 | O75161 | |
| LKEGSSREVPVGIPF | 436 | P32942 | |
| IKDPAVGFLETISPG | 511 | P04062 | |
| PLKVPSELGLGEEFT | 646 | Q8IZE3 | |
| PEIFLVLTATDGGKP | 206 | Q9UN74 | |
| FSPSRIIKEGGIDPV | 1086 | A1KZ92 | |
| ECVELFTERPGPGLK | 241 | O14559 | |
| VFVGKKFEILPDGLP | 281 | Q96NE9 | |
| RGGPEAFDPKRLLEE | 31 | O00471 | |
| EELSGGRLKPKPIDV | 351 | P61158 | |
| GRPTKEILEFPAREV | 526 | Q96HP0 | |
| SRKVFVGGLPPDIDE | 331 | Q7Z5Q1 | |
| LPEVVKKGFADIPTG | 2981 | P49454 | |
| RKVFVGGLPPDIDED | 441 | Q8NE35 | |
| LSGEERVPAIPKEPG | 2401 | Q8TD26 | |
| ELCPRGPGFATKEIT | 1006 | P35555 | |
| FELLRDVTKTPGPGF | 1481 | Q5TH69 | |
| DDGILRSPKGEPVLR | 486 | Q96A23 | |
| EPEFRGQKLVLPEGD | 1031 | Q8N1P7 | |
| LKEPDRIVGEFLQPG | 156 | Q14534 | |
| VESPEAKGGLPEERS | 216 | P28358 | |
| ESEKPRGFARGLEPE | 106 | P83916 | |
| GVPREPFEEKQRIIG | 426 | P09871 | |
| ERDGTLKPGDTIIEP | 131 | P35520 | |
| LDGKIPVSRGFPIAE | 116 | P28067 | |
| PGREEGSPLELERLK | 601 | P08195 | |
| EQTEFLRGPLEGAPK | 1291 | Q5VV63 | |
| RPVETFLTGEPKVLG | 61 | Q8N5U1 | |
| GERTEPLEKTELPEG | 626 | P42701 | |
| ILLGRKPPEFEGGES | 366 | Q9P0L2 | |
| ELGKVRRGVEPKPEA | 2071 | O15021 | |
| DAGEGPSSLIREKPV | 336 | Q9GZR7 | |
| VAKPDVIFRLGPGEE | 51 | Q5JUW0 | |
| IKPRGPIDIDGFAVL | 206 | P20849 | |
| SRKVFVGGLPPDIDE | 471 | Q17RY0 | |
| LEEFSGPEPILVGRL | 71 | P55286 | |
| KPEGSETSVLRGEPL | 311 | Q14689 | |
| GEGFRPNPITIILED | 1636 | P35556 | |
| GELGGLRPIKIEPED | 486 | Q9UHL9 | |
| GIILETVPGEPGRKE | 426 | Q9BQA5 | |
| GGPTVDPEELFRKIF | 176 | Q96EY1 | |
| DGVPRVPEGLEDVSK | 306 | P16444 | |
| RKLGVDGVEEELPPE | 4476 | P21817 | |
| GRKGIFPEPERDPVI | 321 | P28340 | |
| EQKGVPTGFILPIRD | 876 | P11586 | |
| SLEKEFLGAPVGPSV | 66 | Q9H2S9 | |
| TGLRDEKPIKTEVPG | 506 | Q32MZ4 | |
| LLKIEDAPGDGPDVR | 96 | Q96GU1 | |
| VEEGKLRSPDPGILA | 241 | Q9NP80 | |
| VGGLSPDTPEEKIRE | 186 | Q14103 | |
| LSGLPEFVKIVEVGP | 71 | Q8TB92 | |
| PIAFKVVALGDVPDG | 86 | Q01196 | |
| GLREEGLEPKVAFPG | 16 | A2RUB1 | |
| RPGGAIIFTAEEKRP | 951 | Q8N1G1 | |
| GKPIDRGPVVLAEDF | 136 | P21281 | |
| RIGDFIDVSEGPLIP | 256 | Q9NYK5 | |
| KTELIGLPPEFSIGR | 151 | Q9H0K6 | |
| GEGVEFDPLPPKEVR | 91 | Q8N5W9 | |
| AVDPEPGISLKVGDL | 156 | Q5QGS0 | |
| DKFIRLLDAPGIVPG | 296 | Q9NVN8 | |
| DEGVELLGVRPPKRS | 581 | Q9Y2N7 | |
| QEPKPGDLIEIFRLG | 6 | Q9UL19 | |
| KLGTVPLREGFERIP | 26 | Q8WXC3 | |
| PEKGREVAKELGIPY | 171 | Q9BYZ6 | |
| RIEDYGLKPVPGDLV | 491 | Q96PZ0 | |
| REVLESGPLRGAKEP | 26 | O60902 | |
| ESGIPSGKFEVDRIP | 81 | Q99603 | |
| PVTKEGPRDILDGRG | 51 | O95785 | |
| PVEYEIDKTLGIRGP | 91 | P41252 | |
| GDILPPEKGREVAKE | 166 | O94844 | |
| PEKGREVAKELGLPY | 171 | O94844 | |
| EGPPKRVSLVGADDL | 1371 | Q14160 | |
| LSEKRVEPGFVPNKG | 361 | Q86UX6 | |
| GKLGPGVIDLTRPED | 561 | P35712 | |
| VPTLGPKEGSRVRFD | 646 | Q08188 | |
| TPFLAGKEVLGLPDE | 96 | O94911 | |
| PLGLEAEKDGVPVFK | 41 | O75891 | |
| GSPDPIRGEVVKAFI | 501 | Q08AH1 | |
| FDEPGTKTVIPGRVI | 356 | Q96KN2 | |
| IGGLPDPKTLFEIVF | 846 | Q14028 | |
| SKIVDDIPDRPAGIG | 481 | P51790 | |
| RLPDPFAKVVVDGSG | 31 | Q9HAU4 | |
| VTDVAFLPEKGRGPE | 346 | Q9HCU5 | |
| VELSFLPGDTGKPDV | 1391 | Q14690 | |
| EGFLPDPVLRLKGVI | 351 | Q96KV7 | |
| EAGFKRPVVLFGPIA | 726 | Q9UDY2 | |
| KGPRVDPLETELGVK | 421 | Q05086 | |
| SGEKPVLDICRFGLP | 436 | P17023 | |
| LGGIIFGVDEKSPPA | 121 | Q9UBY0 | |
| SPREDGVDGLPKEAV | 6 | Q99469 | |
| REEILAKGGFLPPEE | 136 | Q9H0D6 | |
| VPGFLEKKEPGELAS | 571 | Q9H5I5 | |
| IEVERKFLPGPGTEE | 6 | Q9BU02 | |
| KFLPGPGTEERLQEL | 11 | Q9BU02 | |
| PESGKVVQEGFLREP | 126 | P10636 | |
| PPAEVDGLEIRTGQK | 161 | P49746 | |
| DKEVEFGGPAPRVLS | 1856 | P49750 | |
| KPPFDIGFEGIGEVV | 91 | Q8N4Q0 | |
| IKEVEELQGRPGAFP | 1396 | Q6ZT12 | |
| EILVEPEPLFGAPKR | 86 | O94888 | |
| KLPPGAGVREDVFLV | 326 | Q502W6 | |
| LKRRLEVEPGKESPG | 1071 | O15050 | |
| VGKPDVIFRLGPGDE | 51 | Q2M3X9 | |
| EFGAEIEPPKLLTRP | 1136 | Q9Y4E6 | |
| LPPDIISKAFGGEEV | 1401 | Q5VUA4 | |
| LPGEARLAPISEEGK | 996 | Q96J92 | |
| CFIREVLGDGVPPKV | 46 | Q8NFA0 | |
| IGKPEPLNEEEARGV | 621 | O94782 | |
| IEEVPRPEGKSDKGT | 636 | Q9UPQ9 | |
| PGDKADVGRLSPEVK | 1401 | P49815 | |
| PPTEPIGFDLEIEKR | 426 | Q9ULW0 | |
| DPEGDRTIGILTKPD | 236 | P20591 | |
| LTLEIRKPCPFDGGI | 1236 | Q14896 | |
| KPVPLRGEEGTEATL | 56 | Q15784 |